This observational study is conducted globally. The aim of the study is to investigate the effectiveness and safety of real-life treatment with NorditropinĀ®. The study population will consist of children and adults who are on treatment with NorditropinĀ® in accordance with normal clinical practice.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Effect of NorditropinĀ® treatment on height gain (change in height) in children
Timeframe: Study outcomes (study endpoints) will be analysed and reported on annual basis. The mean follow up period for study outcomes is expected to be 5 years in accordance with defined duration of the study.
Effect of NorditropinĀ® treatment on body weight and body composition in adults
Timeframe: Study outcomes (study endpoints) will be analysed and reported on annual basis. The mean follow up period for study outcomes is expected to be 5 years in accordance with defined duration of the study.